Interferon-γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs

Hepatology

Volumn 35, Issue 3, 2002, Pages 694-703

  Frese, Michael ^a   Schwärzle, Verena ^a   Barth, Kerstin ^a   Krieger, Nicole ^b   Lohmann, Volker ^b   Mihm, Sabine ^c   Haller, Otto ^a   Bartenschlager, Ralf ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c Abteilung Gastroenterologie und Endokrinologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; NITRIC OXIDE; RIBAVIRIN; VIRUS RNA;

ARTICLE; CELL KILLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERADICATION THERAPY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOFLUORESCENCE TEST; NATURAL KILLER CELL; PERSISTENT INFECTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; REPLICON; RNA REPLICATION; VIRUS GENOME; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0036191172     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.31770     Document Type: Article

References (59)

1. Replication of hepatitis C virus
2. Hepatitis C: Global prevalence (update)
3. Hepatitis C: The clinical spectrum of disease
4. Natural history and disease manifestations of hepatitis C infection
5. Current and evolving therapies for hepatitis C
6. Peginterferon alpha-2α in patients with chronic hepatitis C
7. Peginterferon alpha-2α in patients with chronic hepatitis C and cirrhosis
8. Interferons: Cell signalling, immune modulation, antiviral response and virus countermeasures
9. Cellular responses to interferon-γ
10. Plasmacyroid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon
11. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line
12. Mutations in hepatitis C virus RNAs conferring cell culture adaptation
13. Characterization of cell lines carrying self-replicating hepatitis C virus RNAs
14. Interferon-α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway
15. Efficient initiation of HCV RNA replication in cell culture
16. Effect of alpha interferon on the hepatitis C virus replicon
17. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium
18. Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations
19. Characterization of three novel monoclonal antibodies against hepatitis C virus core protein
20. Subcellular localization, stability, and transcleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines
21. Functional properties of a monoclonal antibody inhibiting the hepatitis C virus RNA-dependent RNA polymerase
22. 2-microglobulin expression in different human cell lines by proinflammatory cytokines
23. Interferon-induced gene expression and signalling in human hepatoma cell lines
24. NADPH oxidase, Nramp1 and nitric oxide in the host microbiol response
25. Macrophage oxidation of L-arginine to nitrite and nitrate: Nitric oxide is an intermediate
26. L-N6-(1-iminoethyl)lysine: A selective inhibitor of inducible nitric oxide synthase
27. Schedule and concentration-dependent induction of apoptosis in leukemia cells by nitric oxide
28. N omega-hydroxy-L-arginine, an intermediate in the L-arginine to nitric oxide pathway, is a strong inhibitor of liver and macrophage arginase
29. Inhibition of rat liver arginase by an intermediate in NO synthesis, NG-hydroxy-L-arginase: Implications for the regulation of nitric oxide biosynthesis by arginase
30. Role of IFN-γ-induced indoleamine 2,3 dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells
31. 1-Methyl-DL-tryptophan, β-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and β-[3-benzo(b)-thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase
32. Noncytolytic control of viral infections by the innate and adaptive immune response
33. Viral clearance without destruction of infected cells during acute HBV infection
34. Cytokine-mediated control of viral infections
35. Analysis of a successful immune response against hepatitis C virus
36. + T-cell responsiveness in hepatitis C virus infection
37. Analysis of successful immune responses in persons infected with hepatitis C virus
38. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C
39. T cell responses and intrahepatic cytokine profiles in HBV and HCV-infected chimpanzees
40. Role of cytokine gene polymorphism in hepatitis C recurrence and allograft rejection among liver transplant recipients
41. Different cytokine profiles of peripheral blood mononuclear cells from patients with persistent and self-limited hepatitis C virus infection
42. The natural history of chronic hepatitis C in haemophiliacs
43. High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV
44. Increasing hepatitis C virus RNA levels in hemophiliacs: Relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study
45. Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production
46. gp41 envelope protein of human immunodeficiency virus induces interleukin (IL)-10 in monocytes, but not in B, T, or NK cells, leading to reduced IL-2 and interferon-gamma production
47. Human immunodeficiency and hepatitis C virus coinfection influenced by interferon-gamma
48. Mx proteins: Mediators of innate resistance to RNA viruses
49. The double-stranded RNA-dependent protein kinase PKR: Structure and function
50. How hepatitis C virus counteracts the interferon response: The jury is still out on NS5A
51. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein
52. An antiviral mechanism of nitric oxide: Inhibition of a viral protease
53. Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice
54. Pathogenesis of influenza virus-induced pneumonia: Involvement of both nitric oxide and oxygen radicals
55. Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice
56. Hepatic expression of inducible nitric oxide synthase transcripts in chronic hepatitis C virus infection: Relation to hepatic viral load and liver injury
57. Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation
58. Liver infiltrating T lymphocytes express interferon gamma and inducible nitric oxide synthase in chronic hepatitis C virus infection
59. Interferons and indoleamine 2,3-dioxygenase: Role in antimicrobial and antitumor effects